ES2091057T3 - Composicion medicinal que mejora el metabolismo de los lipidos. - Google Patents

Composicion medicinal que mejora el metabolismo de los lipidos.

Info

Publication number
ES2091057T3
ES2091057T3 ES94104839T ES94104839T ES2091057T3 ES 2091057 T3 ES2091057 T3 ES 2091057T3 ES 94104839 T ES94104839 T ES 94104839T ES 94104839 T ES94104839 T ES 94104839T ES 2091057 T3 ES2091057 T3 ES 2091057T3
Authority
ES
Spain
Prior art keywords
medicinal composition
lipids
metabolism
improves
chem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94104839T
Other languages
English (en)
Spanish (es)
Inventor
Kazumi Ogata
Takahiro Sakaue
Yasuko Umegaki
Rie Nagao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Original Assignee
Senju Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co Ltd filed Critical Senju Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2091057T3 publication Critical patent/ES2091057T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES94104839T 1993-03-31 1994-03-27 Composicion medicinal que mejora el metabolismo de los lipidos. Expired - Lifetime ES2091057T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7381493 1993-03-31

Publications (1)

Publication Number Publication Date
ES2091057T3 true ES2091057T3 (es) 1996-10-16

Family

ID=13529009

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94104839T Expired - Lifetime ES2091057T3 (es) 1993-03-31 1994-03-27 Composicion medicinal que mejora el metabolismo de los lipidos.

Country Status (8)

Country Link
US (1) US5474991A (enExample)
EP (1) EP0617963B1 (enExample)
KR (1) KR100272483B1 (enExample)
AT (1) ATE141508T1 (enExample)
CA (1) CA2116198A1 (enExample)
DE (1) DE69400382T2 (enExample)
ES (1) ES2091057T3 (enExample)
TW (1) TW252918B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922335A (en) * 1995-05-15 1999-07-13 Avon Products, Inc. Uses for ascorbyl-phosphoryl-cholesterol in topical compositions
US5866147A (en) * 1995-05-15 1999-02-02 Avon Products, Inc. Ascorbyl-phosphoryl-cholesterol
US6162450A (en) * 1995-05-15 2000-12-19 Avon Products, Inc. Uses of ascorbyl-phosphoryl-cholesterol and compositions for practicing same
AUPR549901A0 (en) * 2001-06-06 2001-07-12 Vital Health Sciences Pty Ltd Topical formulation containing tocopheryl phosphates
KR100612398B1 (ko) * 2000-11-14 2006-08-16 바이탈 헬스 사이언시즈 피티와이 리미티드 포스페이트 유도체의 착체
JP4745608B2 (ja) * 2001-07-27 2011-08-10 バイタル ヘルス サイエンシズ プロプライアタリー リミティド 電子伝達剤のリン酸誘導体を用いた皮膚治療
CA2466536C (en) * 2001-12-13 2012-02-07 Vital Health Sciences Pty Ltd Transdermal transport of compounds
US20040018959A1 (en) * 2002-05-02 2004-01-29 Randall S. Hickle System and methods of lipid removal from the body
AU2002950713A0 (en) * 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
MXPA05007278A (es) * 2003-01-17 2005-09-30 Vital Health Sciences Pty Ltd Compuestos que tienen propiedades anti-proliferativas.
AU2003901815A0 (en) * 2003-04-15 2003-05-01 Vital Health Sciences Pty Ltd Phosphate derivatives
ATE495730T1 (de) 2004-03-03 2011-02-15 Vital Health Sciences Pty Ltd Alkaloid-formulierungen
EP1861091B1 (en) * 2005-03-03 2013-12-11 Vital Health Sciences Pty Ltd. Compounds having lipid lowering properties
MX2007010492A (es) * 2005-03-03 2007-11-08 Vital Health Sciences Pty Ltd Compuestos que tienen propiedades anticancer.
EP2548581A3 (en) * 2005-06-17 2013-02-20 Vital Health Sciences Pty Ltd. A carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
BRPI0621081A2 (pt) * 2005-12-23 2011-11-29 Vital Health Sciences Pty Ltd método de modulação de uma ou mais citocinas imuno-reguladoras, uso de um ou mais derivados de fosfato de um ou mais hidróxi cromanos ou complexos dos mesmos, método de inibição de uma resposta inflamatória e/ou de estimulação de uma resposta anti-inflamatória, método de tratamento e/ou de profilaxia de distúbios imunológicos, distúrbios inflamatórios e/ou distúrbios proliferativos celulares, agente imuno-modulador, agente anti-inflamatório ou agente anti-cáncer e um ou mais derivado de fosfato de um ou mais hidróxi cromanos ou complexos dos mesmos
ES2999020T3 (en) 2010-02-05 2025-02-24 Phosphagenics Ltd Carrier comprising non-neutralised tocopheryl phosphate
SG184181A1 (en) 2010-03-30 2012-10-30 Phosphagenics Ltd Transdermal delivery patch
EP2685992A4 (en) 2011-03-15 2014-09-10 Phosphagenics Ltd AMINOCHINOLINE AS A KINASEHEMMER
CN108601732A (zh) 2015-12-09 2018-09-28 磷肌酸有限公司 药物制剂
KR102647670B1 (ko) 2016-12-21 2024-03-15 아베초 바이오테크놀로지 리미티드 방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59219295A (ja) * 1983-05-30 1984-12-10 Senjiyu Seiyaku Kk リン酸ジエステルまたはその塩およびそれらの製造法
JPS62205091A (ja) * 1986-03-04 1987-09-09 Senjiyu Seiyaku Kk 新規なリン酸ジエステルならびにその塩、その製造法およびそれを含有する製剤
JPH0781138B2 (ja) * 1986-12-02 1995-08-30 株式会社資生堂 抗酸化剤
JP2526059B2 (ja) * 1987-04-28 1996-08-21 千寿製薬株式会社 抗潰瘍剤
PH25859A (en) * 1988-01-11 1991-12-02 Takeda Chemical Industries Ltd Composition for treatment of ischemic disorder
UA19385A1 (uk) * 1989-04-27 1997-12-25 Сендзю Фармасьютікал Ко. Лтд. Фофоліпідhі похідhі та композиція, яка має аhтиоксидаhтhу та іhгібуючу активhість щодо пероксидів ліпідів
US5053222A (en) * 1989-06-07 1991-10-01 Shiseido Company Ltd. Hair cosmetic composition
US5231090A (en) * 1990-07-30 1993-07-27 University Of Miami Treatment for hypercholesterolemia
CA2099346A1 (en) * 1992-07-17 1994-01-18 Shinji Ohmori Lipid metabolism improving composition

Also Published As

Publication number Publication date
DE69400382D1 (de) 1996-09-26
EP0617963B1 (en) 1996-08-21
KR100272483B1 (ko) 2000-11-15
DE69400382T2 (de) 1996-12-19
TW252918B (enExample) 1995-08-01
CA2116198A1 (en) 1994-10-01
ATE141508T1 (de) 1996-09-15
US5474991A (en) 1995-12-12
EP0617963A1 (en) 1994-10-05
KR940021059A (ko) 1994-10-17

Similar Documents

Publication Publication Date Title
ES2091057T3 (es) Composicion medicinal que mejora el metabolismo de los lipidos.
NO2022019I1 (no) Eribulin eller et farmasøytisk akseptabelt salt derav - forlenget SPC
ES2061204T3 (es) Nuevos derivados de la amino-piperidina, de la amino-pirrolidina y de la amino-perhidroacepina, procedimientos de preparacion y composiciones farmaceuticas que los contienen.
ES2126068T3 (es) Derivados de estilbeno citotoxicos y composicion farmaceutica que los contiene.
ES2081187T3 (es) Nuevas naftil-alquil-aminas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
DK0782827T3 (da) Anvendelse af et afbalanceringsmiddel til omega-6- og omega-3-umættede fedtsyrer
NO944287L (no) Anvendelse av terfenadinderivater som antihistaminmidler i en hepatisk svekket pasient
PT94297A (pt) Processo para a preparacao de n-hetero-aril-purin-6-aminas e de composicoes farmaceuticas que as contem
ES2124477T3 (es) Uso de un fosfato de ascorbilo y tocoferilo para la preparacion de un medicamento para el tratamiento de la pancreatitis.
ES2167388T3 (es) 7-o-eteres de derivados de taxano.
DE69707372D1 (de) Verwendung eines Phosphorsäurediesters zur Herstellung eines Arzneimittels zur Behandlung von Akne
ES2055235T3 (es) Composicion anti-inflamatoria y/o antialergica que comprende derivados de glutation.
DE69001111D1 (de) Antikrebs-zusammensetzung.
EP0605474A4 (enExample)
MX9203712A (es) Derivados de benzanilida y composiciones farmaceuticas que los contienen.
ES2172023T3 (es) Nuevos derivados tetrahidro-piridinicos sustituidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2122221T3 (es) Compuestos terapeuticos adecuados para el tratamiento de enfermedades conectadas con la deficiencia de glutation, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ES2077473T3 (es) Nuevos compuestos tiocromanicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
ES2130548T3 (es) Nuevos derivados alquil-amino-indanos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
FI905918A0 (fi) Heterocykliska foereningar.
ATE171622T1 (de) Antiallergische zusammensetzung enthaltend eine phosphorsäurediester-verbindung
DE69001004D1 (de) Zusammensetzung gegen leberkrankheiten.
ES2069249T3 (es) Derivados de imidazol, su procedimiento de preparacion y los compuestos farmaceuticos que los contienen.
ES2031594T3 (es) Tioeteres aromaticos.
ES2103221B1 (es) Nuevos derivados de bencimidazol-2-tiona, su preparacion y su aplicacion como medicamentos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 617963

Country of ref document: ES

FG2A Definitive protection

Ref document number: 617963

Country of ref document: ES